表纸
市场调查报告书

全球多重检测市场:COVID-19的潜在影响的见解和预测:2020-2024

Global Multiplex Assays (Molecular Multiplexing) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

出版商 Koncept Analytics 商品编码 948343
出版日期 内容资讯 英文 117 Pages
订单完成后即时交付
价格
全球多重检测市场:COVID-19的潜在影响的见解和预测:2020-2024 Global Multiplex Assays (Molecular Multiplexing) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
出版日期: 2020年07月09日内容资讯: 英文 117 Pages
简介

从2020年到2024年,全球多重分析市场预计将以7.18%的复合年增长率增长,到2024年将达到48.7亿美元。市场扩张的驱动力是艾滋病毒感染率上升,新癌症患者病例增加,医疗技术研发支出增加,老年人口增加,医疗费用迅速增加以及药物开发领域。在日本使用多重免疫测定,在制药和生物技术行业中广泛使用伴随诊断,并购,自身免疫性疾病领域中生物仿制药的发展,对多点检验的需求增加(xPOCT)等因素。

该报告调查了全球多重测定市场,包括新的冠状病毒感染性疾病(COVID-19)大流行的影响,全球和区域市场分析,市场动态,竞争格局和公司。我们提供公司资料等信息。

内容

第1章概述

  • 简介
  • 常规分析与多重分析之间的区别
  • 成功进行分子多路复用的因素
  • 多路复用平台
  • 多重分析的未来影像

第2章COVID-19的影响

  • 增加COVID-19检查
  • 政府增加医疗费用
  • 扩大医学领域对人工智能的引入
  • 区域影响

第3章世界市场分析

  • 金额基础的市场
  • 金额基础的市场预测
  • 产品市场
    • 耗材
    • 设备
    • 软件
  • 应用市场
    • 研发
    • 临床诊断市场
    • 伴随诊断
  • 最终用户的市场
    • 制药公司和生物技术公司
    • 研究所
    • 临床实验室
    • 医院
  • 按地区划分的市场

第4章区域市场分析

  • 北美
  • 亚太地区
  • 欧洲
  • 拉丁美洲
  • 中东/非洲

第5章市场动态

  • 促进增长的因素
    • 艾滋病毒感染率上升
    • 新发癌症患者的病例增加
    • 医疗技术研发费用增加
    • 老年人口增加
    • 医疗费用迅速增加
    • 在药物发现中广泛使用多重免疫测定
    • 伴随诊断程序的广泛使用
  • 主要趋势和动向
    • 传染病发病率增加
    • 增加制药和生物技术行业的并购
    • 生物仿制药在自身免疫性疾病领域的发展
    • 对多个即时检验(xPOCT)的需求
  • 挑战
    • 缺乏熟练的专业人员
    • 大型投资资金
    • 各国政府的严格规定

第6章竞争情况

  • 世界市场
    • 主要公司的利润比较
    • 主要公司的研发支出比较
    • 主要公司的市值比较

第7章公司简介

  • Thermo Fisher Scientific
    • 财务概览
    • 财务概览
    • 经营策略
  • Becton,Dickinson and Company(BD)
    • 财务概览
    • 财务概览
    • 经营策略
  • BioMerieux
    • 业务概览
    • 财务概览
    • 经营策略
  • Bio-Rad Laboratories
    • 业务概览
    • 财务概览
    • 经营策略
  • Qiagen
    • 业务概览
    • 财务概览
    • 经营策略
  • Luminex Corporation
    • 业务概览
    • 财务概览
    • 经营策略
目录

The global multiplex assays market is expected to reach US$4.87 billion in 2024, increasing at a CAGR of 7.18%, for the duration spanning 2020-2024. The factors such as increasing prevalence of HIV, rising incidences of cancer cases, increasing medical technology R&D spending, growth in geriatric population, upsurge in healthcare expenditures, rise of multiplex immunoassays in drug discovery and escalating adoption of companion diagnostics would drive the growth of the market. However, the market growth would be challenged by dearth of skilled professionals, high investment capital for multiplex assays and stringent government regulations. A few notable trends may include accelerating growth rates of infectious diseases, growth in pharmaceutical and biotech merger & acquisition, monitoring of biosimilar in autoimmune diseases and demand for multiplexed point-of-care tests (xPOCT).

The global multiplex assays market has been segmented into consumables, instruments and software, based on product type. Consumables dominate the market owing to the increase in the number of testing procedures, performed across research institutes, clinical labs and others. Instruments and software have also hold considerable shares in the global market owing to the technological advancement and product innovation, which have eased the entire process of medical research.

The fastest growing regional market is North America, due to the consistent growth in the M&A between the pharmaceutical and biotechnological companies, which have led to the expansion of the research field in the healthcare sector. Further, the sudden outbreak of COVID-19 is causing an adverse disruption in the global population, augmenting the need for precise diagnostic as well as therapeutic option, which is expected to drive the growth of the global multiplex assays market during the forecasted period.

Scope of the report:

The report provides a comprehensive analysis of the global multiplex assays market.

The major regional markets (North America, Asia-Pacific, Europe, Latin America and Middle East & Africa) have been analyzed.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Thermo Fisher Scientific, Becton, Dickson and Company (BD), BioMerieux, Bio-Rad Laboratories, Qiagen and Luminex Corporation) are also presented in detail.

Key Target Audience:

  • Multiplex Assays Kit Manufacturers
  • Medical Technology and Pharmaceutical Firms
  • End Users (pharma & biotech companies, research institutes, clinical labs and hospitals)
  • Investment Banks
  • Healthcare and Medical Consultants
  • Government Bodies & Regulating Authorities

Table of Contents

1. Overview

  • 1.1. Introduction
  • 1.2. Difference Between Traditional Assay and Multiplex Assay
  • 1.3. Determinants of Successful Molecular Multiplexing
  • 1.4. Multiplexing Platforms
  • 1.5. The Future of Multiplex Assays

2. Impact of COVID-19

  • 2.1. Rise in Number of COVID-19 Test
  • 2.2. Growth in Government Spending on Healthcare
  • 2.3. Rise in Adoption of Artificial Intelligence in Healthcare
  • 2.4. Regional Impact

3. Global Market Analysis

  • 3.1. Global Multiplex Assays Market by Value
  • 3.2. Global Multiplex Assays Market Forecast by Value
  • 3.3. Global Multiplex Assays Market by Product
    • 3.3.1. Global Multiplex Assays Consumables Market by Value
    • 3.3.2. Global Multiplex Assays Consumables Market Forecast by Value
    • 3.3.3. Global Multiplex Assays Instruments Market by Value
    • 3.3.4. Global Multiplex Assays Instruments Market Forecast by Value
    • 3.3.5. Global Multiplex Assays Software Market by Value
    • 3.3.6. Global Multiplex Assays Software Market Forecast by Value
  • 3.4. Global Multiplex Assays Market by Application
    • 3.4.1. Global Multiplex Assays Research & Development Market by Value
    • 3.4.2. Global Multiplex Assays Research & Development Market Forecast by Value
    • 3.4.3. Global Multiplex Assays Clinical Diagnostics Market by Value
    • 3.4.4. Global Multiplex Assays Clinical Diagnostics Market Forecast by Value
    • 3.4.5. Global Multiplex Assays Companion Diagnostics Market by Value
    • 3.4.6. Global Multiplex Assays Companion Diagnostics Market Forecast by Value
  • 3.5. Global Multiplex Assays Market by End-Users
    • 3.5.1. Global P&B Companies Multiplex Assays Market by Value
    • 3.5.2. Global P&B Companies Multiplex Assays Market Forecast by Value
    • 3.5.3. Global Research Institutes Multiplex Assays Market by Value
    • 3.5.4. Global Research Institutes Multiplex Assays Market Forecast by Value
    • 3.5.5. Global Clinical Labs Multiplex Assays Market by Value
    • 3.5.6. Global Clinical Labs Multiplex Assays Market Forecast by Value
    • 3.5.7. Global Hospital Multiplex Assays Market by Value
    • 3.5.8. Global Hospital Multiplex Assays Market Forecast by Value
  • 3.6. Global Multiplex Assays Market by Region

4. Regional Market Analysis

  • 4.1. North America
    • 4.1.1. North America Multiplex Assays Market by Value
    • 4.1.2. North America Multiplex Assays Market Forecast by Value
  • 4.2. Asia-Pacific
    • 4.2.1. Asia-Pacific Multiplex Assays Market by Value
    • 4.2.2. Asia-Pacific Multiplex Assays Market Forecast by Value
  • 4.3. Europe
    • 4.3.1. Europe Multiplex Assays Market by Value
    • 4.3.2. Europe Multiplex Assays Market Forecast by Value
  • 4.4. Latin America
    • 4.4.1. Latin America Multiplex Assays Market by Value
    • 4.4.2. Latin America Multiplex Assays Market Forecast by Value
  • 4.5. Middle East & Africa
    • 4.5.1. Middle East & Africa Multiplex Assays Market by Value
    • 4.5.2. Middle East & Africa Multiplex Assays Market Forecast by Value

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Increasing Prevalence of HIV Infections
    • 5.1.2. Rising Incidences of New Cancer Cases
    • 5.1.3. Increasing Medical Technology R&D Spending
    • 5.1.4. Growth in Geriatric Population
    • 5.1.5. Upsurge in Healthcare Expenditures
    • 5.1.6. Rise of Multiplex Immunoassays in Drug Discovery
    • 5.1.7. Escalating Adoption of Companion Diagnostics
  • 5.2. Key Trends and Developments
    • 5.2.1. Accelerating Growth Rates of Infectious Diseases
    • 5.2.2. Growth in Pharmaceutical and Biotech Merger & Acquisition
    • 5.2.3. Monitoring of Biosimilar in Autoimmune Diseases
    • 5.2.4. Demand for Multiplexed Point-of-Care Tests (xPOCT)
  • 5.3. Challenges
    • 5.3.1. Dearth of Skilled Professionals
    • 5.3.2. High Investment Capital for Multiplex Assays
    • 5.3.3. Stringent Government Regulations

6. Competitive Landscape

  • 6.1. Global Market
    • 6.1.1. Key Players - Revenue Comparison
    • 6.1.2. Key Players - R&D Expenditure Comparison
    • 6.1.3. Key Players - Market Capitalization Comparison

7. Company Profiles

  • 7.1. Thermo Fisher Scientific
    • 7.1.1. Financial Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Business Strategies
  • 7.2. Becton, Dickinson and Company (BD)
    • 7.2.1. Financial Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Business Strategies
  • 7.3. BioMerieux
    • 7.3.1. Business Overview
    • 7.3.2. Financial Overview
    • 7.3.3. Business Strategies
  • 7.4. Bio-Rad Laboratories
    • 7.4.1. Business Overview
    • 7.4.2. Financial Overview
    • 7.4.3. Business Strategies
  • 7.5. Qiagen
    • 7.5.1. Business Overview
    • 7.5.2. Financial Overview
    • 7.5.3. Business Strategies
  • 7.6. Luminex Corporation
    • 7.6.1. Business Overview
    • 7.6.2. Financial Overview
    • 7.6.3. Business Strategies

List of figures

  • Difference Between Traditional Assay and Multiplex Assay
  • Factors for the Rising Adoption of Multiplex Assays
  • Global Government Share on Health Spending (2019-2024)
  • Global Healthcare Artificial Intelligence (AI) Market Forecast (2017-2021)
  • Global Multiplex Assays Market by Value (2015-2019)
  • Global Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by Product (2019)
  • Global Multiplex Assays Consumables Market by Value (2015-2019)
  • Global Multiplex Assays Consumables Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Instruments Market by Value (2015-2019)
  • Global Multiplex Assays Instruments Forecast by Value (2020-2024)
  • Global Multiplex Assays Software Market by Value (2015-2019)
  • Global Multiplex Assays Software Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by Application (2019)
  • Global Multiplex Assays Research & Development Market by Value (2015-2019)
  • Global Multiplex Assays Research & Development Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Clinical Diagnostics Market by Value (2015-2019)
  • Global Multiplex Assays Clinical Diagnostics Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Companion Diagnostics Market by Value (2015-2019)
  • Global Multiplex Assays Companion Diagnostics Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by End-Users (2019)
  • Global P&B Companies Multiplex Assays Market by Value (2015-2019)
  • Global P&B Companies Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Research Institutes Multiplex Assays Market by Value (2015-2019)
  • Global Research Institutes Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Clinical Labs Multiplex Assays Market by Value (2015-2019)
  • Global Clinical Labs Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Hospital Multiplex Assays Market by Value (2015-2019)
  • Global Hospital Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by Region (2019)
  • North America Multiplex Assays Market by Value (2015-2019)
  • North America Multiplex Assays Market Forecast by Value (2020-2024)
  • Asia-Pacific Multiplex Assays Market by Value (2015-2019)
  • Asia-Pacific Multiplex Assays Market Forecast by Value (2020-2024)
  • Europe Multiplex Assays Market by Value (2015-2019)
  • Europe Multiplex Assays Market Forecast by Value (2020-2024)
  • Latin America Multiplex Assays Market by Value (2015-2019)
  • Latin America Multiplex Assays Market Forecast by Value (2020-2024)
  • Middle East & Africa Multiplex Assays Market by Value (2015-2019)
  • Middle East & Africa Multiplex Assays Market Forecast by Value (2020-2024)
  • Global HIV Infected Population (2015-2019)
  • Global New Cases of Top Cancer Types (2019)
  • Global Medical Technology R&D Spending (2015-2019)
  • Global Geriatric Population - Age 65 and Above (2015-2019)
  • Global Healthcare Expenditure Per Capita (2015-2019)
  • Global Pharmaceutical R&D Spending (2015-2019)
  • Global Growth Rate of Infectious Diseases Forecast (2017-2022)
  • Global Pharmaceutical and Biotech M&A (2015-2019)
  • Thermo Fisher Scientific Revenue and Net Income (2015-2019)
  • Thermo Fisher Scientific Revenue by Segments (2019)
  • Thermo Fisher Scientific Revenue by Regions (2019)
  • Becton, Dickinson and Company Revenue and Net Income (2015-2019)
  • Becton, Dickinson and Company Revenue by Segments (2019)
  • Becton, Dickinson and Company Revenue by Regions (2019)
  • BioMerieux Net Sales and Net Income (2015-2019)
  • BioMerieux Net Sales by Product Application (2019)
  • BioMerieux Net Sales by Regions (2019)
  • Bio-Rad Laboratories Net Sales and Net Income (2015-2019)
  • Bio-Rad Laboratories Net Sales by Segments (2019)
  • Bio-Rad Laboratories Net Sales by Regions (2019)
  • Qiagen Net Sales and Net Loss (Income) (2015-2019)
  • Qiagen Net Sales by Product Classes (2019)
  • Qiagen Net Sales by Regions (2019)
  • Luminex Corporation Total Revenue and Net Loss (Income) (2015-2019)
  • Luminex Corporation Total Revenue by Source (2019)
  • Luminex Corporation Total Revenue by Regions (2019)

List of Tables

  • Determinants of Successful Molecular Multiplexing
  • Multiplexing Platforms
  • COVID-19 Test per Million Population
  • Key Players - Revenue Comparison (2019)
  • Key Players - R&D Expenditure Comparison (2019)
  • Key Players - Market Capitalization Comparison (2020)